Bull & Bear

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Watchlist — the operating cash engine is unambiguously strong, but the decisive evidence (FY26 ROIC reversion, post-Leonard CSU hurdle language, tape inflection) is not yet in the file, and a hostile distribution tape removes any reason to chase. Bull is right that FY2025 was a record cash year being mispriced against a one-time non-cash Asseco reversal; Bear is right that ROIC collapsed to 10.4%, the Asseco minority stake is the first deployment outside the stated VMS framework, and the 34× FCFA2S print on the correct denominator is not a margin of safety. The debate hinges on a single question that the data does not yet resolve: is the FY25 ROIC dip a clean denominator effect from late-year acquisitions, or the first observable signature of hurdle-rate compression in a re-priced European VMS funnel? FY26 H1 ROIC and organic-maintenance prints are the load-bearing observables — both arrive inside the next two reporting cycles, and neither is currently in hand. Until then, the bull thesis is intellectually correct on operations but premature on tape; the bear thesis is intellectually correct on structure but unproven on direction.

Bull Case

Bull's price target is $103/share on 20× P/FCF applied to FY27 base-case FCF of $588m (≈ $90/share) plus ~$13/share for the Asseco stake at carrying value, equivalent to 32× FCFA2S on FY27 FCFA2S of $398m. Timeline is 18 months, anchored on Q1 FY2026 MD&A through FY2026 annuals (Feb 2027) — the first non-Asseco-distorted print of consolidated net income. The disconfirming signal is maintenance organic growth printing sub-3% for two consecutive quarters across TOI + CSU + LMN — the only observable that breaks the switching-cost moat thesis directly.

Bear Case

Bear's downside target is $42/fully-diluted share (≈ $5.5B equity value) on P/FCFA2S compression from ~34× to 18× as the compounder narrative breaks — FY27 FCFA2S of ~$305m (modest growth with hurdle compression) × 18× ÷ 129.8m diluted shares. Timeline is 12–18 months, anchored on the first post-Leonard CSU President's Letter showing any softening of the 20–30% IRR language. The cover signal is FY26 ROIC ≥ 13% AND organic maintenance ≥ +6% AND CSU letter restating 20–30% without qualification — that combination means the FY25 dip was a clean denominator effect and the funnel is intact.

The Real Debate

Verdict

Watchlist. Bear carries slightly more weight today because the structural arguments — NCI leakage, fully-diluted denominator, 34× FCFA2S on the correct math, and a distribution tape that has not reversed since the October 2025 death cross — are observable now, while Bull's anchor (FY26 ROIC reversion to 14–16% as the FY25 deployment cohort annualises) is a forward-looking claim that the file cannot yet verify. The decisive tension is what ROIC 10.4% means: a clean denominator effect from late-year deployment versus the first observable signature of European VMS hurdle compression. Bull could still be right — record FY25 cash, +6% maintenance organic, no SBC, audit clean, and a CEO with ~$2.6B of effective stock are not the fingerprints of a deteriorating compounder, and one quarter of mean-reversion would re-rate the operating multiple cleanly. The verdict moves to Lean Long on the joint condition of (a) Q1 or Q2 FY26 ROIC printing in the 13–16% band, (b) maintenance organic holding ≥ +6%, and (c) the post-Leonard CSU letter restating the 20–30% IRR target without softening qualifiers. Absent any of those three, the right institutional behaviour is to keep the file open, watch the next print, and refuse to chase a stock that the tape is still distributing.